首页 | 本学科首页   官方微博 | 高级检索  
     


Chemical genomics: a challenge for de novo drug design
Authors:P. M. Dean
Affiliation:(1) De Novo Pharmaceuticals Ltd, Vision Park, Compass House, Histon, Cambridge, CB4 9ZR, UK
Abstract:De novo design provides an in silico toolkit for the design of novel small molecular structures to a set of specified structural constraints. With the avalanche of bioinformatics data, de novo design is ideally suited for exploring molecules that could be useful for chemical genomics. The design process involves manipulation of the input, modification of structural constraints, and further processing of the de novo generated molecules using various modular toolkits. The development of a theoretical framework for each of these stages will provide novel practical solutions to the problem of creating compounds with maximal chemical diversity. This short review describes the fundamental problems encountered in the application of novel chemical design technologies to chemical genomics by means of a formal representation. This notation helps to outline and clarify ideas and hypotheses that can then be explored using mathematical algorithms. It is only by developing this rigorous foundation that in silico design can progress in a rational way.
Keywords:Drug design  Pharmacogenomics  Gene expression  Polymorphism  Metabolism  Site similarity  Design criteria  Structure-based design
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号